Ertapenem Versus Meropenem for the Treatment of Extended Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia in Critically Ill Patients

Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia: A Propensity-Matched, Retrospective Cohort Study

(2023) Evan L Steere et al.   Open Forum Infectious Diseases

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

(2023) Pranita D Tamma et al.   CLINICAL INFECTIOUS DISEASES

Thirty-Day Mortality Rates in Patients with Extended-Spectrum β-Lactamase-Producing Enterobacterales Bacteremia Receiving Ertapenem versus Other Carbapenems

(2022) Jin Ju Park et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of Clinical Outcomes among Intensive Care Unit Patients Receiving One or Two Grams of Ceftriaxone Daily

(2020) Andrew Ackerman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Are standard dosing regimens of ceftriaxone adapted for critically ill patients with augmented creatinine clearance? A prospective observational study.

(2019) Julien Ollivier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

(2018) Patrick N. A. Harris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study

(2015) O. Zusman et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

(2012) Vicki L. Collins et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penetration of Ertapenem into Muscle Measured by In Vivo Microdialysis in Mechanically Ventilated Patients

(2011) I. Boyadjiev et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients

(2010) Marta Ulldemolins et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis

(2008) A.J. Brink et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS